Search Browse Earnings

Galecto, Inc. — SlamSEC

Galecto, Inc.

Nasdaq:GLTO

Pharmaceutical Preparations·BOSTON, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$39.6M

FY 2024

Net Income

-$38.3M

FY 2024

EPS (Diluted)

-$36.08

FY 2024

Stock Price

$28.68

+1.1%

2026-03-09

52W Range

$2.01 – $38.33

P/E Ratio

-0.8x

Market Cap

$38.1M

Cash

$21.5M

FY 2024

Total Debt

—

Net Cash

$21.5M

Enterprise Value

$16.6M

Debt / EBITDA

0.5x

FY 2024

EV / EBITDA

-0.4x

Employees

—